CD19+ Acute Leukemia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (NCT06773936) | SWOG Cancer Research Network | 2026-04-13 |
| A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia (NCT02028455) | Seattle Children's Hospital | 2014-02-11 |
Track CD19+ Acute Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.